319 related articles for article (PubMed ID: 35352319)
21. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
22. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.
Simitsopoulou M; Peshkova P; Tasina E; Katragkou A; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2013 Jun; 57(6):2562-70. PubMed ID: 23529739
[TBL] [Abstract][Full Text] [Related]
23. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
[TBL] [Abstract][Full Text] [Related]
24. Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against
Fais R; Rizzato C; Franconi I; Tavanti A; Lupetti A
Microbiol Spectr; 2022 Aug; 10(4):e0124022. PubMed ID: 35876581
[No Abstract] [Full Text] [Related]
25. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006.
Dannaoui E; Lortholary O; Raoux D; Bougnoux ME; Galeazzi G; Lawrence C; Moissenet D; Poilane I; Hoinard D; Dromer F;
Antimicrob Agents Chemother; 2008 Feb; 52(2):778-81. PubMed ID: 18070978
[TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
[TBL] [Abstract][Full Text] [Related]
28. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
Toutounji M; Tokajian S; Khalaf RA
Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
[TBL] [Abstract][Full Text] [Related]
29. Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
Deorukhkar SC; Saini S
Infect Disord Drug Targets; 2016; 16(1):63-8. PubMed ID: 26648186
[TBL] [Abstract][Full Text] [Related]
30. Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance.
Papp C; Kocsis K; Tóth R; Bodai L; Willis JR; Ksiezopolska E; Lozoya-Pérez NE; Vágvölgyi C; Mora Montes H; Gabaldón T; Nosanchuk JD; Gácser A
mSphere; 2018 Nov; 3(6):. PubMed ID: 30429225
[No Abstract] [Full Text] [Related]
31. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of CLSI M44-A2 disk diffusion and associated breakpoint testing of caspofungin and micafungin using a well-characterized panel of wild-type and fks hot spot mutant Candida isolates.
Arendrup MC; Park S; Brown S; Pfaller M; Perlin DS
Antimicrob Agents Chemother; 2011 May; 55(5):1891-5. PubMed ID: 21357293
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
[TBL] [Abstract][Full Text] [Related]
34. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
35. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
[TBL] [Abstract][Full Text] [Related]
36. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
37. In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.
Andes D; Diekema DJ; Pfaller MA; Bohrmuller J; Marchillo K; Lepak A
Antimicrob Agents Chemother; 2010 Jun; 54(6):2497-506. PubMed ID: 20385855
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
[TBL] [Abstract][Full Text] [Related]
39. Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of
Yang F; Zhang L; Wakabayashi H; Myers J; Jiang Y; Cao Y; Jimenez-Ortigosa C; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223384
[TBL] [Abstract][Full Text] [Related]
40. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
